RSS   Newsletter   Contact   Advertise with us

Aviva to sell majority shareholding in Aviva Singapore for 1.9 billion

Christian Fernsby ▼ | September 12, 2020
Aviva has agreed to sell a majority shareholding in Aviva Singapore to a consortium led by Singapore Life (Singlife) to support the creation of one of the country’s leading insurance companies.
Aviva Singapore
Aviva   Aviva Singapore
The combination brings together Aviva Singapore’s scale and leading franchise with Singlife’s innovative and digitally focused capabilities.

Topics: Aviva

In Singapore, the new business will be initially branded as Aviva Singlife.

The Singlife consortium includes TPG, a leading global private equity investor, which will become the largest shareholder in the new group upon completion, Sumitomo Life, a leading Japanese insurer, and other existing Singlife shareholders.

On completion, Aviva will receive SGD 2.7 billion (£1.6 billion) in consideration, which is comprised of SGD 2.0 billion (£1.2 billion) in cash and marketable securities1, SGD 250 million in vendor finance notes and a 25% equity shareholding in the new group.

The transaction represents a multiple of 18.7x Aviva Singapore’s 2019 IFRS profit after tax, 2.0x Solvency II Own Funds at 30 June 2020 and 1.9x Net Asset Value at 30 June 2020.

The transaction would have increased Aviva plc’s Net Asset Value at 30 June by £0.7 billion2, strengthened Solvency II capital surplus by £0.5 billion and increased the Group Solvency ratio on a shareholder basis by approximately 4 percentage points.

In 2019, Aviva Singapore’s IFRS profit after tax was £83 million and it remitted £46 million cash to the group.

The gross assets of Aviva Singapore were £6.6 billion at 30 June 2020.

Customers and partners of Aviva Singapore will continue to deal with Aviva as usual and there is no impact to customer policies as a result of this announcement3.

Aviva Investors’ operations and clients in Asia will not be impacted by this transaction.

The proceeds will be used to further strengthen Aviva’s central liquidity and will be considered as part of Aviva’s broader capital management and debt reduction objectives.

The transaction is subject to customary closing conditions, including regulatory approval, and is expected to complete by January 2021.


 

MORE INSIDE POST